Correlation Between Creative Edge and Delta 9
Can any of the company-specific risk be diversified away by investing in both Creative Edge and Delta 9 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Creative Edge and Delta 9 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Creative Edge Nutrit and Delta 9 Cannabis, you can compare the effects of market volatilities on Creative Edge and Delta 9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Creative Edge with a short position of Delta 9. Check out your portfolio center. Please also check ongoing floating volatility patterns of Creative Edge and Delta 9.
Diversification Opportunities for Creative Edge and Delta 9
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Creative and Delta is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Creative Edge Nutrit and Delta 9 Cannabis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Delta 9 Cannabis and Creative Edge is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Creative Edge Nutrit are associated (or correlated) with Delta 9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Delta 9 Cannabis has no effect on the direction of Creative Edge i.e., Creative Edge and Delta 9 go up and down completely randomly.
Pair Corralation between Creative Edge and Delta 9
If you would invest 1.26 in Delta 9 Cannabis on September 1, 2024 and sell it today you would lose (0.46) from holding Delta 9 Cannabis or give up 36.51% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Creative Edge Nutrit vs. Delta 9 Cannabis
Performance |
| Timeline |
| Creative Edge Nutrit |
| Delta 9 Cannabis |
Creative Edge and Delta 9 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Creative Edge and Delta 9
The main advantage of trading using opposite Creative Edge and Delta 9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Creative Edge position performs unexpectedly, Delta 9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Delta 9 will offset losses from the drop in Delta 9's long position.| Creative Edge vs. Benchmark Botanics | Creative Edge vs. Speakeasy Cannabis Club | Creative Edge vs. City View Green | Creative Edge vs. BC Craft Supply |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |